 A sustained release formulation exists, sold as Ketodur, in some countries containing 10 or 25 mg ketobemidone.Experiments on former addicts indicated it was quite addictive and in high doses, compared to other opioids, may have increased abuse potential in former and current opioid addicts.While some effort was first suggested for drafting of a resolution urging governments to stop manufacture and use of ketobemidone.